Key result
Remote monitoring for patients with heart failure and cardiac implantable electronic devices did not reduce overall mortality or hospital readmissions, but did reduce healthcare costs and presentations.
Why the study?
Whether the demonstrated benefits of remote monitoring of CIEDs translate into improvements in heart failure management remains controversial.
Does remote monitoring of cardiac implantable electronic devices reduce mortality and hospital readmissions in patients with heart failure?
Meta-Analysis (n=6,579)
Does remote monitoring of cardiac implantable electronic devices reduce mortality and hospital readmissions in patients with heart failure?
Remote monitoring of CIEDs in heart failure patients reduces healthcare costs and clinic visits but does not improve mortality or heart failure readmission rates.
No takes yet. Share an insight, caveat, or question.
Does not support remote CIED monitoring to reduce HF mortality or readmissions; confirms no hard-endpoint benefit despite cost reductions.
McGee et al. (2022) conducted a meta-analysis in Heart failure with cardiac implantable electronic devices (n=6,579). Remote monitoring was evaluated on Mortality and hospital readmissions. Remote monitoring for patients with heart failure and cardiac implantable electronic devices did not reduce overall mortality or hospital readmissions, but did reduce healthcare costs and presentations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: